DailyDoctor Archive Specialties Get app
All neurology briefings

The edition · Neurology

Anticoagulating intermediate-risk atrial fibrillation cut strokes in a randomised trial

SINGLE-AF gives randomised support to a class IIa recommendation; pooled trials back thrombectomy beyond 4.5 hours but leave bridging tenecteplase unproven; and midlife p-tau181 tracked memory decline two decades later.

The edition in brief

SINGLE-AF randomised 1,803 Korean patients with atrial fibrillation and a CHA2DS2-VASc score of 1 (men) or 2 (women) to a DOAC or no anticoagulation. Over two years, the composite of stroke, embolism, major bleeding or cardiovascular death occurred in 0.5% versus 1.5% (HR 0.31, 95% CI 0.10–0.94), and strokes in 0.3% versus 1.1%, with no apparent excess in major bleeding. Event numbers were small and the trial open-label, but it is the first randomised evidence for a recommendation that rested on observational data. A Bayesian network meta-analysis of eight trials in confirmed large-vessel or basilar occlusion treated 4.5 to 24 hours after onset found thrombectomy improved functional independence (OR 2.93) and reduced mortality, while adding tenecteplase before thrombectomy gave imprecise estimates (OR 1.10, credible interval 0.34–3.52). In 1,515 ARIC participants, higher plasma p-tau181 in midlife was associated with faster memory decline 20 years later, and late-life p-tau181, NfL and GFAP all tracked decline. These markers are not ready for use in cognitively normal people. A French population study showed that the tissue-based stroke definition in ICD-11 raises measured incidence by 6.5%, more in people under 55. The pearl covers how to document a transient event with a positive scan.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for neurology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free